Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Frontage Labs Opens Clinical-Stage CRO in Jilin Hospital

publication date: Dec 23, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Frontage Laboratories officially opened a renovated clinical-stage facility in Jilin University Hospital, which it has been operating since earlier this year. Frontage is a US-China CRO with a pre-clinical toxicology facility in Shanghai and a drug development operation in Beijing. The Jilin hospital facility will offer early phase oncology research studies. More details....

Share this with colleagues:    

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...